Are critical normal gene products in cancer cells the real therapeutic targets?

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2651-2655

  Warenius, Hilmar M ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Duncan Building   (United Kingdom)

Author keywords

Cancer cells; Gene products; Therapeutic targets

Indexed keywords

GENE PRODUCT;

CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL DIVISION; CELL PROLIFERATION; CHROMOSOME ABERRATION; CRITICAL NORMAL GENE; DIPLOIDY; GENE; GENE DISRUPTION; GENE EXPRESSION; GENE FUNCTION; GENETIC DAMAGE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

CELL DIVISION; DRUG DESIGN; HUMANS; MUTATION; NEOPLASM PROTEINS; NEOPLASMS;

EID: 0036765394     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Ilyas M, Straub J, Tomlinson IP and Bodmer WF: Genetic pathways in colorectal and other cancers. Eur J Cancer 35: 335-351, 1999.
2. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57 -70, 2000.
3. Sliwkowski MX, Lofgren JA, Lewis GD, Hotaling TE, Fendly BM and Fox JA: Non-clinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin Oncol 4: suppl. 12: 60-70, 1999.
4. Baselga J: Clinical trials of Herceptin (R) (trastuzumab). Eur J Cancer 37: suppl.1, 18-24, 2001.
5. Adjei AA, Ehrlichmann C, Davis JN, Cutler DL, Sloan JA, Marks RS, Hanson LJ, Svingen PA, Atherton P, Bishop WR, Kirschmeier P and Kaufmann FH: A phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity. Cancer Res 60: 1871-1877, 2000.
6. Nemunaitis J, Ganly I, Khuri F, Arsenau J, Kuhn J, McCarty T, Landers S, Maples P, Romel I, Randlev B, Reid T, Kaye S and Kirn D: Selective replication and oncolysis in p53 mutant tumours with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A phase II trial. Cancer Res 60: 6359-6366, 2000.
7. Mauro MJ and Druker BJ: STI571: Targetting BCR-ABL as therapy for CML. Oncologist 6: 233-238, 2001.
8. Meltzer PS and Trent JM: Chromosome rearrangements in human solid tumours. In: The Genetic Basis of Human Cancer (Bert Vogelstein and Kenneth W Kinzler, eds), New York, McGraw-Hill Health Professions Division, 1998.
9. Mitelman F, Mertens F and Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Natur Genet 15 Spec No: 417-474, 1997.
10. Preface. In: The Genetic Basis of Human Cancer (Bert Vogelstein and Kenneth W Kinzler, eds), New York, McGraw-Hill Health Professions Division, 1998.
11. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenheim NB, Cho KR, Riggins GJ and Morin P: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60: 6281-6287, 2000.
12. Waghray A, Schober M, Feroze F, Yao F, Virgin J and Chen YQ: Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer. Cancer Res 61: 4283-4286, 2001.
13. Wang T, Hopkins D, Schmidt C, Silva S, Houghton R, Takita H, Repasky E and Reed SG: Identification of genes differentially over-expressed in lung squamous cell carcinoma using a combination of cDNA subtraction and microarray analysis. Oncogene 19: 1519-1528, 2000.
14. Shackney ES and Shankey TV: Genetic and phenotypic heterogeneity of human malignancies: Finding order chaos. Cytometry 21: 2-5, 1995.
15. Harada K, Nishizaki T, Ozaki S, Kubota H, Ito H and Sasaki K: Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridisation and laser scanning cytometry in human gliomas. Cancer Res 58: 4694-4700, 1998.
16. Loeb LA: Many mutations in cancers. In: Genetic Instability in Cancer (T Lindahl, ed) New York, Cold Spring Harbor Laboratory Press, 10 Skyline Drive, Plainview, 1996.
17. Lengauer C, Kinzler KW and Vogelstein B: Genetic instabilities in human cancers. Nature 396: 643-649, 1998.
18. Weinstein IB: Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis 21: 857-864, 2000.
19. Jones JL and Walker RA: Integrins: A role as cell signalling molecules. Mol Pathol 52: 208-213, 1999.
20. Hill CS: The Smads. Int J Biochem Cell Biol 31: 1249-1254, 1999.
21. Miller JR, Hocking AM, Brown JD and Moon RT: Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene 18: 7860-7872, 1999.
22. McCormick F: Signalling networks that cause cancer. Trends Cell Biol 9: 53-56, 1999.
23. Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M and Land H: Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes and Development 11: 663-677, 1997.
24. Mihich E and Harlow E: Twelth Annual Pezcoller Symposium: Signalling cross-talks in cancer cells. Cancer Res 60: 7177-7183, 2000.
25. Bhalla S and Iyengar R: Emergent properties of networks of biological signaling pathways. Science 283: 381-390, 1999.
26. Kohn KW: Functional capabilities of molecular network components controlling the mammalian cell cycle phase transition. Oncogene 16: 1065-1075, 1998.
27. Sgambato AA, Cittadini A and Weinstein IB: Multiple functions of p27Kip1 and its alterations in tumor cells. A review. J Cell Physiol 183: 18-27, 2000.
28. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillet CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ and Lu X: High level expression of p27(kip1) and cyclin D1 in come human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94: 6380-6385, 1997.
29. Kip1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res 58: 1042-1047, 1998.
30. Kip1 in human breast cancers. Clin Cancer Res 3: 1879-1887, 1997.
31. Weinstein IB, Begemann M, Zhou P, Han EK-H, Sgambato A, Doki Y, Arber N, Ciaparrone M and Yamamoto H: Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin Cancer Res 3: 2696-2702, 1997.
32. Wildrick DM and Boman BM: Does the human retinoblastoma gene have a role in colon cancer? Mol Carcinogenesis 10: 1-7, 1994.
33. Yamamoto H, Soh J-W, Klein MG, Zhang LM, Schieren I, Stein CA and Weinstein IB: Paradoxical increase in retinoblastoma protein in colorectal cancers may protect cells from apoptosis. Clin Cancer Res 5: 1805-1815, 1999.
34. Seabra LA and Warenius HM: Wild-type CDK1 and CDK4 proteins are co-elevated in human cancer. Proc Am Ass Cancer Res 39: 442, 1998.
35. Preston RJ: Telomeres, telomerase and chromosomal stability. Rad Research 147: 529-534, 1997.